within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AB11_Valaciclovir;

model Valaciclovir
  extends Pharmacolibrary.Drugs.ATC.J.J05AB11;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J05AB11</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Valaciclovir is an antiviral prodrug that is rapidly converted in vivo to acyclovir, an agent used primarily for the treatment of herpes simplex virus (HSV) infections and varicella-zoster virus (VZV) infections. It is approved and commonly used today for herpes simplex (genital herpes, cold sores), herpes zoster (shingles), and, sometimes, for cytomegalovirus prophylaxis in transplant patients.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after a single oral dose of valaciclovir 1000 mg, values reported for acyclovir (active metabolite).</p><h4>References</h4><ol><li><p>MacDougall, C, &amp; Guglielmo, BJ (2004). Pharmacokinetics of valaciclovir. <i>The Journal of antimicrobial chemotherapy</i> 53(6) 899–901. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkh244&quot;>10.1093/jac/dkh244</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15140857/&quot;>https://pubmed.ncbi.nlm.nih.gov/15140857</a></p></li><li><p>Leung, AKC, &amp; Barankin, B (2017). Herpes Labialis: An Update. <i>Recent patents on inflammation &amp; allergy drug discovery</i> 11(2) 107–113. DOI:<a href=&quot;https://doi.org/10.2174/1872213X11666171003151717&quot;>10.2174/1872213X11666171003151717</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28971780/&quot;>https://pubmed.ncbi.nlm.nih.gov/28971780</a></p></li><li><p>Lebrun-Vignes, B (2002). [Valaciclovir]. <i>Annales de dermatologie et de venereologie</i> 129(5 Pt 1) 708–715. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12124513/&quot;>https://pubmed.ncbi.nlm.nih.gov/12124513</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Valaciclovir;
